- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Control Hyperphosphatemia segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) include Akebia, Astellas, Takeda, Vifor, and Abbvie, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Control Hyperphosphatemia
Maintain Blood Calcium Levels
Control PTH Level
Correct Acidosis
Other
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Other
The key market players for global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market are listed below:
Akebia
Astellas
Takeda
Vifor
Abbvie
Fresenius
Abbott
Novadiol
Japan Tobacco Company
Daiichi-Sankyo
Shield
Spectrum
OPKO
Ardelyx
Sanofi Genzyme
Amgen
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), with price, sales, revenue and global market share of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) from 2019 to 2022.
Chapter 3, the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD).
Chapter 13, 14, and 15, to describe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Control Hyperphosphatemia
1.2.3 Maintain Blood Calcium Levels
1.2.4 Control PTH Level
1.2.5 Correct Acidosis
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Drug Stores
1.3.6 Other
1.4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size & Forecast
1.4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume (2017-2028)
1.4.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (2017-2028)
1.5 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Capacity Analysis
1.5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Total Production Capacity (2017-2028)
1.5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Drivers
1.6.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Restraints
1.6.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Trends Analysis
2 Manufacturers Profiles
2.1 Akebia
2.1.1 Akebia Details
2.1.2 Akebia Major Business
2.1.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.1.4 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Astellas
2.2.1 Astellas Details
2.2.2 Astellas Major Business
2.2.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.2.4 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business
2.3.3 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.3.4 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Vifor
2.4.1 Vifor Details
2.4.2 Vifor Major Business
2.4.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.4.4 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Abbvie
2.5.1 Abbvie Details
2.5.2 Abbvie Major Business
2.5.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.5.4 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Fresenius
2.6.1 Fresenius Details
2.6.2 Fresenius Major Business
2.6.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.6.4 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business
2.7.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.7.4 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novadiol
2.8.1 Novadiol Details
2.8.2 Novadiol Major Business
2.8.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.8.4 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Japan Tobacco Company
2.9.1 Japan Tobacco Company Details
2.9.2 Japan Tobacco Company Major Business
2.9.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.9.4 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Daiichi-Sankyo
2.10.1 Daiichi-Sankyo Details
2.10.2 Daiichi-Sankyo Major Business
2.10.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.10.4 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Shield
2.11.1 Shield Details
2.11.2 Shield Major Business
2.11.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.11.4 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Spectrum
2.12.1 Spectrum Details
2.12.2 Spectrum Major Business
2.12.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.12.4 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 OPKO
2.13.1 OPKO Details
2.13.2 OPKO Major Business
2.13.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.13.4 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Ardelyx
2.14.1 Ardelyx Details
2.14.2 Ardelyx Major Business
2.14.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.14.4 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Sanofi Genzyme
2.15.1 Sanofi Genzyme Details
2.15.2 Sanofi Genzyme Major Business
2.15.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.15.4 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Amgen
2.16.1 Amgen Details
2.16.2 Amgen Major Business
2.16.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.16.4 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Breakdown Data by Manufacturer
3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
3.4 Market Concentration Rate
3.4.1 Top 3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturer Market Share in 2021
3.4.2 Top 6 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturer Market Share in 2021
3.5 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region
4.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Region (2017-2028)
4.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2017-2028)
4.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2017-2028)
4.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2017-2028)
4.4 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2017-2028)
4.5 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2017-2028)
4.6 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Type (2017-2028)
5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2017-2028)
5.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Application (2017-2028)
6.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2017-2028)
6.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2028)
7.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2028)
7.3 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country
7.3.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Country (2017-2028)
7.3.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2028)
8.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2028)
8.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country
8.3.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Country (2017-2028)
8.3.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2028)
9.2 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2028)
9.3 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region
9.3.1 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2028)
10.2 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2028)
10.3 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country
10.3.1 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Country (2017-2028)
10.3.2 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2028)
11.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2028)
11.3 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country
11.3.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
12.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Process
12.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Typical Distributors
13.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Akebia Basic Information, Manufacturing Base and Competitors
Table 4. Akebia Major Business
Table 5. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 6. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Astellas Basic Information, Manufacturing Base and Competitors
Table 8. Astellas Major Business
Table 9. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 10. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Takeda Basic Information, Manufacturing Base and Competitors
Table 12. Takeda Major Business
Table 13. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 14. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Vifor Basic Information, Manufacturing Base and Competitors
Table 16. Vifor Major Business
Table 17. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 18. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Abbvie Basic Information, Manufacturing Base and Competitors
Table 20. Abbvie Major Business
Table 21. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 22. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Fresenius Basic Information, Manufacturing Base and Competitors
Table 24. Fresenius Major Business
Table 25. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 26. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Abbott Basic Information, Manufacturing Base and Competitors
Table 28. Abbott Major Business
Table 29. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 30. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Novadiol Basic Information, Manufacturing Base and Competitors
Table 32. Novadiol Major Business
Table 33. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 34. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Japan Tobacco Company Basic Information, Manufacturing Base and Competitors
Table 36. Japan Tobacco Company Major Business
Table 37. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 38. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Daiichi-Sankyo Basic Information, Manufacturing Base and Competitors
Table 40. Daiichi-Sankyo Major Business
Table 41. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 42. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Shield Basic Information, Manufacturing Base and Competitors
Table 44. Shield Major Business
Table 45. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 46. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Spectrum Basic Information, Manufacturing Base and Competitors
Table 48. Spectrum Major Business
Table 49. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 50. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. OPKO Basic Information, Manufacturing Base and Competitors
Table 52. OPKO Major Business
Table 53. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 54. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Ardelyx Basic Information, Manufacturing Base and Competitors
Table 56. Ardelyx Major Business
Table 57. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 58. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Sanofi Genzyme Basic Information, Manufacturing Base and Competitors
Table 60. Sanofi Genzyme Major Business
Table 61. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 62. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Amgen Basic Information, Manufacturing Base and Competitors
Table 64. Amgen Major Business
Table 65. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 66. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 68. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 69. Market Position of Manufacturers in Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 70. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Capacity by Company, (MT): 2020 VS 2021
Table 71. Head Office and Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Site of Key Manufacturer
Table 72. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) New Entrant and Capacity Expansion Plans
Table 73. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Mergers & Acquisitions in the Past Five Years
Table 74. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2017-2022) & (MT)
Table 75. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2023-2028) & (MT)
Table 76. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2017-2022) & (USD Million)
Table 77. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2023-2028) & (USD Million)
Table 78. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2022) & (MT)
Table 79. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2023-2028) & (MT)
Table 80. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2017-2022) & (USD Million)
Table 81. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2023-2028) & (USD Million)
Table 82. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2017-2022) & (USD/Kg)
Table 83. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2023-2028) & (USD/Kg)
Table 84. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2022) & (MT)
Table 85. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2023-2028) & (MT)
Table 86. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2017-2022) & (USD Million)
Table 87. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2023-2028) & (USD Million)
Table 88. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2017-2022) & (USD/Kg)
Table 89. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2023-2028) & (USD/Kg)
Table 90. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2017-2022) & (MT)
Table 91. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2023-2028) & (MT)
Table 92. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2017-2022) & (USD Million)
Table 93. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2023-2028) & (USD Million)
Table 94. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2022) & (MT)
Table 95. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2023-2028) & (MT)
Table 96. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2022) & (MT)
Table 97. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2023-2028) & (MT)
Table 98. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2017-2022) & (MT)
Table 99. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2023-2028) & (MT)
Table 100. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2017-2022) & (USD Million)
Table 101. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2023-2028) & (USD Million)
Table 102. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2022) & (MT)
Table 103. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2023-2028) & (MT)
Table 104. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2022) & (MT)
Table 105. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2023-2028) & (MT)
Table 106. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2017-2022) & (MT)
Table 107. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2023-2028) & (MT)
Table 108. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2017-2022) & (USD Million)
Table 109. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2023-2028) & (USD Million)
Table 110. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2022) & (MT)
Table 111. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2023-2028) & (MT)
Table 112. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2022) & (MT)
Table 113. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2023-2028) & (MT)
Table 114. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2017-2022) & (MT)
Table 115. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2023-2028) & (MT)
Table 116. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2017-2022) & (USD Million)
Table 117. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2023-2028) & (USD Million)
Table 118. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2022) & (MT)
Table 119. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2023-2028) & (MT)
Table 120. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2022) & (MT)
Table 121. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2023-2028) & (MT)
Table 122. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2017-2022) & (MT)
Table 123. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2023-2028) & (MT)
Table 124. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2017-2022) & (USD Million)
Table 125. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2023-2028) & (USD Million)
Table 126. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2022) & (MT)
Table 127. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2023-2028) & (MT)
Table 128. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2022) & (MT)
Table 129. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2023-2028) & (MT)
Table 130. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Raw Material
Table 131. Key Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Raw Materials
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Typical Distributors
Table 135. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Typical Customers
List of Figures
Figure 1. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Picture
Figure 2. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type in 2021
Figure 3. Control Hyperphosphatemia
Figure 4. Maintain Blood Calcium Levels
Figure 5. Control PTH Level
Figure 6. Correct Acidosis
Figure 7. Other
Figure 8. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application in 2021
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Drug Stores
Figure 13. Other
Figure 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (2017-2028) & (MT)
Figure 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (2017-2028) & (USD/Kg)
Figure 18. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Capacity (2017-2028) & (MT)
Figure 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Capacity by Geographic Region: 2022 VS 2028
Figure 20. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Drivers
Figure 21. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Restraints
Figure 22. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Trends
Figure 23. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Manufacturer in 2021
Figure 24. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Manufacturer in 2021
Figure 25. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 26. Top 3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturer (Revenue) Market Share in 2021
Figure 27. Top 6 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturer (Revenue) Market Share in 2021
Figure 28. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2017-2028)
Figure 29. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2017-2028)
Figure 30. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2017-2028) & (USD Million)
Figure 31. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2017-2028) & (USD Million)
Figure 32. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2017-2028) & (USD Million)
Figure 33. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2017-2028) & (USD Million)
Figure 34. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2017-2028) & (USD Million)
Figure 35. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2017-2028)
Figure 36. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2017-2028)
Figure 37. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2017-2028) & (USD/Kg)
Figure 38. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2017-2028)
Figure 39. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2017-2028)
Figure 40. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2017-2028) & (USD/Kg)
Figure 41. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2017-2028)
Figure 42. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2017-2028)
Figure 43. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2017-2028)
Figure 44. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2017-2028)
Figure 45. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2017-2028)
Figure 49. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2017-2028)
Figure 50. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2017-2028)
Figure 51. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2017-2028)
Figure 52. Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2017-2028)
Figure 61. China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2017-2028)
Figure 68. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2017-2028)
Figure 69. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2017-2028)
Figure 70. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2017-2028)
Figure 74. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2017-2028)
Figure 75. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2017-2028)
Figure 76. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2017-2028)
Figure 77. Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Egypt Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Manufacturing Cost Structure Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in 2021
Figure 82. Manufacturing Process Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Figure 83. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industrial Chain
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
